The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
Open accessAbstract
Genes showing higher expression in either tumor or metastatic tissues can help in better understanding tumor formation and can serve as biomarkers of progression or as potential therapy targets. Our goal was to establish an integrated database using available transcriptome-level datasets and to create a web platform which enables the mining of this database by comparing normal, tumor and metastatic data across all genes in real time. We utilized data generated by either gene arrays from the Gene Expression Omnibus of the National Center for Biotechnology Information (NCBI-GEO) or RNA-seq from The Cancer Genome Atlas (TCGA), Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and The Genotype-Tissue Expression (GTEx) repositories. The altered expression within different platforms was analyzed separately. Statistical significance was computed using Mann–Whitney or Kruskal–Wallis tests. False Discovery Rate (FDR) was computed using the Benjamini–Hochberg method. The entire database contains 56,938 samples, including 33,520 samples from 3180 gene chip-based studies (453 metastatic, 29,376 tumorous and 3691 normal samples), 11,010 samples from TCGA (394 metastatic, 9886 tumorous and 730 normal), 1193 samples from TARGET (1 metastatic, 1180 tumorous and 12 normal) and 11,215 normal samples from GTEx. The most consistently upregulated genes across multiple tumor types were TOP2A (FC = 7.8), SPP1 (FC = 7.0) and CENPA (FC = 6.03), and the most consistently downregulated gene was ADH1B (FC = 0.15). Validation of differential expression using equally sized training and test sets confirmed the reliability of the database in breast, colon, and lung cancer at an FDR below 10%. The online analysis platform enables unrestricted mining of the database and is accessible at TNMplot.com.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4_9 · Cited by 12,516
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 3×
“The National Cancer Institute’s Genomic Data Commons (GDC) platform provides whole exome sequencing data and transcriptome-level gene expression datasets, such as The Cancer Genome Atlas (TCGA) [6] and the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) [7].”
Influentialaffy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Durinck, S., Spellman, P. T., Birney, E., & Huber, W. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,197
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Toward a Shared Vision for Cancer Genomic Data
Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607591 · Cited by 1,680
Gene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,184
Lowe, R., Shirley, N., Bleackley, M., Dolan, S., & Shafee, T. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005457 · Cited by 1,176
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Hallek, M. (2019) · American Journal of Hematology · doi:10.1002/ajh.25595 · Cited by 504
Topoisomerases as anticancer targets
Delgado, J. L., Hsieh, C.-M., Chan, N.-L., & Hiasa, H. (2018) · Biochemical Journal · doi:10.1042/bcj20160583 · Cited by 481
Fekete, J. T., & Győrffy, B. (2019) · International Journal of Cancer · doi:10.1002/ijc.32369 · Cited by 422
Self-citationJetset: selecting the optimal microarray probe set to represent a gene
Li, Q., Birkbak, N. J., Gyorffy, B., Szallasi, Z., & Eklund, A. C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-474 · Cited by 324
The Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263 · cited 1×
“The Genotype-Tissue Expression (GTEx) repository makes available RNA sequencing, exome sequencing and whole genomic data for the same patient [8].”
MethodGuidelines for the selection of functional assays to evaluate the hallmarks of cancer
Menyhárt, O., Papp, H., Sukumar, S. V., Schäfer, R., Magnani, L., de Barrios, O., & Győrffy, B. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.002 · Cited by 167
Self-citationA selective review of robust variable selection with applications in bioinformatics
Wu, C., & Ma, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu046 · Cited by 121
Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review
Jasra, S., & Anampa, J. D. S. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0547-8 · Cited by 74
Kropotova, E. S., Zinovieva, O. L., Zyryanova, A. F., Dybovaya, V. I., Prasolov, V. S., Beresten, S. F., Oparina, N. Y., & Mashkova, T. D. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9751-4 · Cited by 66
Cederleuf, H., Pedersen, M. B., Jerkeman, M., Relander, T., d’Amore, F., & Ellin, F. (2017) · British Journal of Haematology · doi:10.1111/bjh.14740 · Cited by 50
Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer
Wang, P., Zhang, L., Huang, C., Huang, P., & Zhang, J. (2018) · Medical Science Monitor · doi:10.12659/msm.910026 · Cited by 40
Sulakhe, D., D’Souza, M., Wang, S., Balasubramanian, S., Athri, P., Xie, B., Canzar, S., Gady Agam, B., Gilliam, T. C., & Maltsev, N. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby047 · Cited by 37
Cited by
Győrffy, B. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100625 · Cited by 464
Self-citationDiscovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
Győrffy, B. (2023) · GeroScience · doi:10.1007/s11357-023-00742-4 · Cited by 381
Self-citationAlsaafin, A., Safarpoor, A., Sikaroudi, M., Hipp, J. D., & Tizhoosh, H. R. (2023) · Communications Biology · doi:10.1038/s42003-023-04583-x · Cited by 40
(2022) · doi:10.7554/elife.76823 · Cited by 24
Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression
Moreira, A. M., Ferreira, R. M., Carneiro, P., Figueiredo, J., Osório, H., Barbosa, J., Preto, J., Pinto-do-Ó, P., Carneiro, F., & Seruca, R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.818552 · Cited by 21
Metadata
- Authors
- Bartha, Á., & Győrffy, B.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-03-05
- Volume
- 22
- Issue
- 5
- Pages
- 2622
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3135882325
- Cited by
- 1,060
- References
- 25
- FWCI
- 45.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.